TOP TIERMARKET NEWSWIRE
News & sentiment

DAMORA THERAPEUTICS (DMRA) — News & AI sentiment

DAMORA THERAPEUTICS (DMRA) news roundup. 2 stories in the past week, 7 over 30 days. Average 30-day sentiment is 54/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $7K — net selling of $7K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 58.5/100
30d stories
7
avg sentiment 54/100
Insider net (90d)
$7K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on DMRA

6d ago
Jefferies initiates Damora Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
6d ago
H.C. Wainwright reiterates Buy on Damora Therapeutics stock
Investing.com Analyst Ratings61 · neutralanalyst
Jul 21
Jul 20
Jul 20
Jul 17
Jul 17
Jul 1
Jun 17
Jun 1
May 30
May 27
May 5
Open DMRA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →